News about Engineering

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

Today, the U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer

Engineering | 01/07/2020 | By Darshana

FDA Approves New Therapy for Dravet Syndrome

FDA Approves New Therapy for Dravet Syndrome

The U.S. Food and Drug Administration today approved Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older. Dravet syndrome is a life-threatening, rare and chronic form of epilepsy. It is often characterized by severe and unrelenting seizures

Engineering | 29/06/2020 | By Darshana

Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithm

Roche improves speed and accuracy of non-small cell lung cancer diagnosis with launch of automated digital pathology algorithm

today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The algorithm provides pathologists with automated assessments of scanned slide images that are objective and reproducible and have the potential to aid diagnosis

Engineering | 26/06/2020 | By Darshana

Cipla launches generic remdesivir for COVID-19

Cipla launches generic remdesivir for COVID-19

Cipla Limited announced the launch of generic version of remdesivir under its brand name Cipremi. The US FDA issued an emergency use authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients

Engineering | 22/06/2020 | By Darshana

Glenmark Pharma launches favipiravir drug for COVID-19 treatment

Glenmark Pharma launches favipiravir drug for COVID-19 treatment

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has launched antiviral drug favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients

Engineering | 22/06/2020 | By Darshana

App launched by Pharma cos to market products and educate doctors about new drugs in the wake of lockdown crisis

App launched by Pharma cos to market products and educate doctors about new drugs in the wake of lockdown crisis

On the lines of the medical apps being used by healthcare professionals and chronic patients to avail information on medicines and doctors? services, the pharmaceutical manufacturing companies worldwide have started launching Pharma Apps to educate doctors and hospital administrators about new drugs

Engineering | 16/06/2020 | By Darshana

ICMR advises States to conduct sero-survey to measure Coronavirus exposure in the population using IgG ELISA Test

ICMR advises States to conduct sero-survey to measure Coronavirus exposure in the population using IgG ELISA Test

The COVID19 pandemic has so far affected 216 countries and caused more than 59.31 lakh cases and 3.65 lakh deaths worldwide

Engineering | 02/06/2020 | By Darshana

FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19

FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19

Today, the U.S. Food and Drug Administration took important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance with recommendations for innovators and researchers conducting work in this area

Engineering | 12/05/2020 | By Darshana

Aurobindo Pharma receives US FDA approval for generic Ancobon capsules

Aurobindo Pharma receives US FDA approval for generic Ancobon capsules

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (FDA) to manufacture and market flucytosine capsules, 250 mg and 500 mg

Engineering | 04/05/2020 | By Darshana

New 6-year data for Roche's OCREVUS show earlier treatment initiation halves risk of needing walking aid in relapsing multiple scleros

New 6-year data for Roche's OCREVUS show earlier treatment initiation halves risk of needing walking aid in relapsing multiple scleros

These new analyses add additional evidence to the benefit-risk profile of OCREVUS, including the impact of MS on people?s daily lives. The data were selected for the 72nd American Academy of Neurology (AAN) Annual Meeting and will be made available online via virtual presentation in the coming weeks

Engineering | 30/04/2020 | By Darshana

 
 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology